EXTON,
Pa., April 14, 2022 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that it will release first-quarter 2022 financial results
before the market opens on Thursday, April
28, 2022, and will follow with a conference call to discuss
the results and business expectations at 9:00 a.m. Eastern Time. To participate on the
call, please dial 877-930-8295 (U.S.) or 253-336-8738
(International). The conference ID is 6690124.
A live broadcast of the conference call will be available at the
Company's website, www.westpharma.com, in the "Investors" section.
Management will refer to a slide presentation during the call,
which will be made available on the day of the call. To view the
presentation, select "Presentations" in the "Investors" section of
the Company's website.
An online archive of the broadcast will be available at the site
three hours after the live call and will be available through
Thursday, May 5, 2022, by dialing
855-859-2056 (U.S.) or 404-537-3406 (International). The
conference ID is 6690124.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With
approximately 10,000 team members across 50 sites worldwide, West
helps support our customers by delivering over 45 billion
components and devices each year.
Headquartered in Exton,
Pennsylvania, and in business for nearly a century, West in
its fiscal year 2021 generated $2.83
billion in net sales. West is traded on the New York Stock
Exchange (NYSE: WST) and is included on the Standard & Poor's
500 index. For more information, visit www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States
and other jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-to-host-first-quarter-2022-conference-call-301525455.html
SOURCE West Pharmaceutical Services, Inc.